Cargando…
Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features
The primary treatment for non-functioning pituitary tumors (NFPTs) is surgery, but it is often unsuccessful. Previous studies have reported that NFPTs express receptors for somatostatin (SST(1-5)) and dopamine (DRDs) providing a rationale for the use of dopamine agonists and somatostatin analogues....
Autores principales: | Flores-Martinez, Álvaro, Venegas-Moreno, Eva, Dios, Elena, Remón-Ruiz, Pablo, Gros-Herguido, Noelia, Vázquez-Borrego, M. Carmen, Madrazo-Atutxa, Ainara, Japón, Miguel A., Kaen, Ariel, Cárdenas-Valdepeñas, Eugenio, Roldán, Florinda, Castaño, Justo P., Luque, Raúl M., Cano, David A., Soto-Moreno, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565399/ https://www.ncbi.nlm.nih.gov/pubmed/32971845 http://dx.doi.org/10.3390/jcm9093052 |
Ejemplares similares
-
MON-467 Expression of Somatostatin Receptors in Aggressive Non-Functioning Pituitary Adenomas
por: Soto, Alfonso, et al.
Publicado: (2019) -
Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
por: Venegas‐Moreno, Eva, et al.
Publicado: (2017) -
E‐cadherin expression is associated with somatostatin analogue response in acromegaly
por: Venegas‐Moreno, Eva, et al.
Publicado: (2019) -
A Silent Corticotroph Pituitary Carcinoma: Lessons From an Exceptional Case Report
por: Remón-Ruiz, Pablo, et al.
Publicado: (2021) -
Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features
por: Vázquez-Borrego, Mari C., et al.
Publicado: (2019)